FCGR3A and hematocrit: MCs with a high expression level of CD14 in PBMCs of HT patients were classified as classical CD14+ monocytes (CD14+mono), while MCs that abundantly expressed FCGR3A (CD16) were labeled as nonclassical CD16+ monocytes (CD16+mono) [19].